OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

SKU Category Vector Description Price Delivery
RC206847 CDNA CLONE PS100001 PAK4 (Myc-DDK-tagged)-Human p21 protein (Cdc42/Rac)-activated kinase 4 (PAK4), transcript variant 2 $560 Immediate
RC206847L1 CDNA CLONE PS100064 Lenti ORF clone of Human p21 protein (Cdc42/Rac)-activated kinase 4 (PAK4), transcript variant 2 , Myc-DDK-tagged $740 Immediate
RC206847L1V CDNA CLONE PS100064 Lenti ORF particles, PAK4 (Myc-DDK tagged) - Human p21 protein (Cdc42/Rac)-activated kinase 4 (PAK4), transcript variant 2 , 0.5 mL, >10^6 TU/mL $1140 2-3 weeks
RC206847L2 CDNA CLONE PS100071 Lenti ORF clone of Human p21 protein (Cdc42/Rac)-activated kinase 4 (PAK4), transcript variant 2, mGFP tagged $810 3-4 weeks
RC206847L2V CDNA CLONE PS100071 Lenti ORF particles, PAK4 (mGFP-tagged) - Human p21 protein (Cdc42/Rac)-activated kinase 4 (PAK4), transcript variant 2, 0.5 mL, >10^6 TU/mL $1250 6-7 weeks
RC506847 CDNA CLONE PS100001 PAK4 (Myc-DDK-tagged)-Human p21 protein (Cdc42/Rac)-activated kinase 4 (PAK4), transcript variant 2, (200ug) $680 1-2 weeks
RG206847 CDNA CLONE PS100010 PAK4 (GFP-tagged) - Human p21 protein (Cdc42/Rac)-activated kinase 4 (PAK4), transcript variant 2 $610 2-3 weeks
SC301961 CDNA CLONE pCMV6-Entry PAK4 (untagged)-Human p21 protein (Cdc42/Rac)-activated kinase 4 (PAK4), transcript variant 2 NM_001014831.1 $700 2-3 weeks
SC320565 CDNA CLONE pCMV6-AC PAK4 (untagged)-Human p21 protein (Cdc42/Rac)-activated kinase 4 (PAK4), transcript variant 2 NM_001014831.2 $700 Immediate
Still don't see what you are looking for? Try the comprehensive search
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title